KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.7800
+0.0243 (3.22%)
At close: Oct 31, 2025, 4:00 PM EDT
0.8099
+0.0299 (3.83%)
After-hours: Oct 31, 2025, 7:10 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $5.48 million as of October 31, 2025. Its market cap has decreased by -77.37% in one year.
Market Cap
5.48M
Enterprise Value
3.46M
1-Year Change
-77.37%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $5.48M, a decrease of -98.73%. That is a compound annual growth rate of -40.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 5.50M | -82.81% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |